Effects of second-line antihyperglycemic drugs on the risk of chronic kidney disease: applying a target trial approach to a hospital-based cohort of Thai patients with type 2 diabetes

BACKGROUND: The reno-protective effect of second-line treatments in type 2 diabetes has been assessed by clinical trials but generalizability to routine clinical practice is still uncertain. We aimed to assess the effectiveness of these treatments, when added to metformin, on the risk of chronic kid...

Descripción completa

Detalles Bibliográficos
Autores principales: Siriyotha, Sukanya, Lukkunaprasit, Thitiya, Looareesuwan, Panu, Nimitphong, Hataikarn, McKay, Gareth J., Attia, John, Thakkinstian, Ammarin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9670521/
https://www.ncbi.nlm.nih.gov/pubmed/36397062
http://dx.doi.org/10.1186/s12933-022-01641-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9670521/
https://www.ncbi.nlm.nih.gov/pubmed/36397062
http://dx.doi.org/10.1186/s12933-022-01641-2

Ejemplares similares